Article
Diverse point mutations in the human gene for polymorphic N-acetyltransferase.
Proceedings of the National Academy of Sciences of the United States of America - 15 Jul 1991
Vatsis K P, Martell K J, Weber W W
Abstract excerpt
Classification of humans as rapid or slow acetylators is based on hereditary differences in rates of N-acetylation of therapeutic and carcinogenic agents, but N-acetylation of certain arylamine drugs displays no genetic variations. Two highly homologous human genes for N-acetyltransferase (NAT; arylamine acetyltransferase, acetyl CoA:arylamine N-acetyltransferase, EC 2.3.1.5), NAT1 and NAT2, presumably code for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
